CompletedNCT03932877

Serum Soluble Endoglin and Matrix Metalloproteinase 14 With Elisa Method in Early/Late-onset Preeclampsia

Studying Preeclampsia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Cengiz Gokcek Women's and Children's Hospital
Principal Investigator
Ali Ovayolu
Cengiz Gokcek WCH
Intervention
MMP-14 and s-ENG levels(other)
Enrollment
125 target
Eligibility
18-35 years · FEMALE
Timeline
20182018

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03932877 on ClinicalTrials.gov

Other trials for Preeclampsia

Additional recruiting or active studies for the same condition.

See all trials for Preeclampsia

← Back to all trials